Júlia Dos Santos Monteiro, Rafael Reis de Oliveira, Ocílio Ribeiro Gonçalves, Beatriz Borba E Silva, Izabely Dos Reis de Paula, Maria Antonia Oliveira Machado Pereira, Davi Santos Lima, Jacy Bezerra Parmera, Rubens Gisbert Cury, João Paulo Mota Telles
{"title":"Magnetic resonance-guided focused ultrasound for essential tremor patients with low skull density ratio: A systematic review and meta-analysis.","authors":"Júlia Dos Santos Monteiro, Rafael Reis de Oliveira, Ocílio Ribeiro Gonçalves, Beatriz Borba E Silva, Izabely Dos Reis de Paula, Maria Antonia Oliveira Machado Pereira, Davi Santos Lima, Jacy Bezerra Parmera, Rubens Gisbert Cury, João Paulo Mota Telles","doi":"10.1016/j.parkreldis.2025.107936","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is a non-invasive treatment option for essential tremor (ET). Its use is often limited to patients with a skull density ratio (SDR) above 0.4, despite reports of positive outcomes in those with lower SDR.</p><p><strong>Methods: </strong>A systematic review and meta-analysis were conducted according to Cochrane and PRISMA guidelines. We searched PubMed, Embase, and Cochrane Library for studies reporting clinical outcomes, sonication strategies, and adverse effects related to MRgFUS for ET according to SDR ratios. Low SDR was defined as ≤ 0.4, while high SDR was categorized as > 0.4. Data were analyzed using a random-effects model in RStudio 4.4.0, with standardized mean difference (SMD) and 95 % confidence interval (CI) used to compare tremor improvements.</p><p><strong>Results: </strong>Five studies, including a total of 505 patients, were analyzed. Tremor reduction in patients with low SDR showed a pooled mean improvement of 48.81 % (95 % CI: 40.59 %-57.03 %) at three months post-treatment. Sustained tremor improvement was observed after 12 months, with a pooled mean of 45.58 % (95 % CI: 37.96 %-53.21 %). Comparison between low SDR and high SDR groups revealed no statistically significant difference in tremor improvement (SMD = -0.02; 95 % CI: -0.46 to 0.42; p = 0.93), indicating similar treatment responses.</p><p><strong>Conclusions: </strong>These findings suggest that MRgFUS is an effective treatment for ET patients with low SDR, with sustainable tremor reduction up to one year post-treatment and comparable outcomes to those with higher SDR.</p>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":" ","pages":"107936"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.parkreldis.2025.107936","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is a non-invasive treatment option for essential tremor (ET). Its use is often limited to patients with a skull density ratio (SDR) above 0.4, despite reports of positive outcomes in those with lower SDR.
Methods: A systematic review and meta-analysis were conducted according to Cochrane and PRISMA guidelines. We searched PubMed, Embase, and Cochrane Library for studies reporting clinical outcomes, sonication strategies, and adverse effects related to MRgFUS for ET according to SDR ratios. Low SDR was defined as ≤ 0.4, while high SDR was categorized as > 0.4. Data were analyzed using a random-effects model in RStudio 4.4.0, with standardized mean difference (SMD) and 95 % confidence interval (CI) used to compare tremor improvements.
Results: Five studies, including a total of 505 patients, were analyzed. Tremor reduction in patients with low SDR showed a pooled mean improvement of 48.81 % (95 % CI: 40.59 %-57.03 %) at three months post-treatment. Sustained tremor improvement was observed after 12 months, with a pooled mean of 45.58 % (95 % CI: 37.96 %-53.21 %). Comparison between low SDR and high SDR groups revealed no statistically significant difference in tremor improvement (SMD = -0.02; 95 % CI: -0.46 to 0.42; p = 0.93), indicating similar treatment responses.
Conclusions: These findings suggest that MRgFUS is an effective treatment for ET patients with low SDR, with sustainable tremor reduction up to one year post-treatment and comparable outcomes to those with higher SDR.
期刊介绍:
Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.